[HTML][HTML] Human recombinant soluble ACE2 in severe COVID-19
A Zoufaly, M Poglitsch, JH Aberle… - The Lancet …, 2020 - thelancet.com
The Lancet Respiratory Medicine, 2020•thelancet.com
Human recombinant soluble ACE2 in severe COVID-19 - The Lancet Respiratory Medicine Skip
to Main Content Advertisement The Lancet Respiratory Medicine Submit Article Log in Register
Log in Submit Article Log in Subscribe Skip menu This journal Read Online first Current issue
All issues Series Commissions About About the journal Alerts Request institutional access
External Link Multimedia Podcasts External Link Journals Journals The Lancet The Lancet
Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet Digital Health …
to Main Content Advertisement The Lancet Respiratory Medicine Submit Article Log in Register
Log in Submit Article Log in Subscribe Skip menu This journal Read Online first Current issue
All issues Series Commissions About About the journal Alerts Request institutional access
External Link Multimedia Podcasts External Link Journals Journals The Lancet The Lancet
Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet Digital Health …
Angiotensin converting enzyme 2 (ACE2) is the crucial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor and protects multiple tissues, including the lung, from injury as a regulator of the renin–angiotensin system.
thelancet.com